How Much Does Walking Actually Lower Blood Pressure? A 32-Trial Answer
pooled 32 randomized controlled trials of walking as the only treatment, lasting at
least four weeks, in people who were inactive at baseline. Walking lowered systolic
blood pressure by 3.58 mmHg (95% CI −5.19 to −1.97) and diastolic by
1.54 mmHg (95% CI −2.83 to −0.26). It also reduced body weight by
1.37 kg, BMI by 0.53 kg/m² and body fat by 1.22
percentage points, and raised aerobic capacity by 3.04 mL/kg/min. And it
failed to alter blood lipids. That last result is as informative as the others,
because it shows the analysis was capable of finding nothing.
Walking gets recommended constantly and quantified rarely. “It’s good for you” is true and it does
not tell you whether the effect is large enough to matter, or which parts of your health it touches.
This analysis answers that with numbers, and the numbers are modest, real, and uneven across
outcomes.
What was pooled
The review, published in Preventive Medicine (PMID 25579505), identified
32 articles reporting the effects of walking interventions. The inclusion rules are
the reason the result is interpretable:
- Randomized controlled trials
- Walking as the only treatment, compared against a no-exercise group
- At least four weeks in duration
- Participants inactive at baseline
Walking as the only treatment matters more than it sounds. A great deal of exercise research bundles
activity with dietary advice, coaching or weight-loss targets, which makes it impossible to say which
component did the work. Here the intervention is the walking.
Inactive at baseline matters too, and in the other direction: it limits who the result describes.
These are the gains available to someone going from nothing to something, which is the largest
improvement available in any activity intervention.
The numbers
| Outcome | Change | 95% CI |
|---|---|---|
| Systolic blood pressure | −3.58 mmHg | −5.19 to −1.97 |
| Diastolic blood pressure | −1.54 mmHg | −2.83 to −0.26 |
| Body weight | −1.37 kg | −1.75 to −1.00 |
| BMI | −0.53 kg/m² | −0.72 to −0.35 |
| Body fat | −1.22 percentage points | −1.70 to −0.73 |
| Aerobic capacity (VO₂max) | +3.04 mL/kg/min | 2.48 to 3.60 |
| Blood lipids | No change | — |
Every confidence interval above sits entirely on one side of zero, which is what statistical
significance looks like when you read intervals rather than asterisks.
Is 3.58 mmHg worth anything?
It sounds small next to the numbers on a blood pressure monitor, and at the level of one person it
is a modest shift. Its significance is different at two scales.
For a population, small average reductions in systolic pressure translate into
meaningfully fewer strokes and heart attacks, because blood pressure risk is continuous rather than
switched on at a threshold. Shifting an entire distribution by a few millimetres moves a lot of people
across a lot of small margins.
For you, it is one input among several. Medication, sodium, alcohol, weight and
sleep all act on the same number, and a walking programme is not a substitute for treatment anyone has
prescribed. What the figure does establish is that walking alone, with nothing else changed, moves the
measurement in a direction you would want.
The result that makes the others believable
Walking failed to alter blood lipids.
That is worth pausing on rather than skipping. An analysis that finds benefit on every single
outcome invites the suspicion that the method was tuned to find benefit. An analysis that finds clear
effects on blood pressure, weight, body composition and fitness, and nothing at all on cholesterol, has
demonstrated that its instruments were capable of returning a null result.
It also sets a boundary on the claim. If your reason for walking is your cholesterol panel, this
body of evidence does not support the expectation, and that is more useful to know in advance than
after six months.
What the analysis does not tell you
How far or how fast to walk. The review pooled interventions of at least four weeks with walking as
the only treatment; it does not resolve the pace, distance or frequency that produced these averages,
and different trials used different protocols.
Whether the effects persist. Trials of four weeks and upward capture the change during the
intervention. They say much less about what remains a year later, which is a general weakness of
exercise research rather than a flaw in this review.
Whether it applies to already-active people. Participants were inactive at baseline by design.
Someone already walking regularly is not the person these effect sizes describe, and the honest
expectation for them is smaller.
Why “walking as the only treatment” is the important phrase
It is easy to skim past, and it is what separates this analysis from most of what gets written about
exercise and health.
A large share of activity research tests a programme: exercise plus dietary counselling,
plus goal-setting, plus regular contact with a researcher. Those trials often produce impressive
results, and they cannot tell you which ingredient produced them. If the walking group also got advice
about vegetables and a weekly phone call, the effect belongs to the package.
Restricting the pool to trials where walking was the only treatment, against a no-exercise
comparator, means the numbers above are attributable to the walking itself. It is a stricter filter, it
leaves fewer trials in the analysis, and it makes the surviving result far more useful to anyone
deciding whether to bother.
The same discipline explains the modest size of the effects. A programme with coaching and diet
attached would show bigger changes in weight and lipids. Walking on its own shows this much, and this
much is what you get if walking on its own is what you do.
Frequently Asked Questions
How much does walking lower blood pressure?
In this meta-analysis of 32 randomized trials, walking reduced systolic blood pressure by 3.58 mmHg
(95% CI −5.19 to −1.97) and diastolic by 1.54 mmHg (95% CI −2.83 to −0.26) in previously inactive
adults. Both intervals sit entirely below zero, meaning the effect is statistically significant. The
size is modest at an individual level and meaningful at a population level.
Does walking help with weight?
Modestly, and the numbers are specific: 1.37 kg of body weight, 0.53 kg/m² of BMI and 1.22 percentage
points of body fat, all with confidence intervals excluding zero. That is a real change and it is not a
weight-loss programme. Walking as the only intervention, without dietary change, produces roughly this
much, which is worth knowing before setting expectations.
Does walking improve cholesterol?
Not according to this analysis, which states that walking failed to alter blood lipids. That is a
clear negative result rather than an ambiguous one, and it is arguably the most useful line in the
paper because it tells you what walking alone will not fix. If lipids are the target, the evidence
points elsewhere, and that is a conversation for a clinician.
Does it improve fitness?
Yes, and this was the largest relative effect: aerobic capacity rose by 3.04 mL/kg/min (95% CI 2.48
to 3.60). VO₂max is a measure of how much oxygen your body can use during exercise, and it is one of the
stronger predictors of long-term health outcomes. For people starting from inactivity, walking moved it
reliably.
Who were the participants?
Adults who were inactive at baseline, in trials where walking was the only treatment compared against
a no-exercise group, lasting at least four weeks. That design is unusually clean for exercise research,
because it isolates walking rather than bundling it with diet or coaching. It also means the effect
sizes describe going from nothing to something, which is the biggest available improvement.
How much should I walk?
This analysis cannot tell you, because it pooled trials with different protocols and reported
averages across them rather than a dose response. What it establishes is that walking programmes of at
least four weeks produced these changes. For a specific target, national physical activity guidelines
give weekly minute recommendations, and a clinician can set something appropriate if you have a
condition.
Can walking replace my blood pressure medication?
No, and nothing here suggests it. A 3.58 mmHg average reduction from walking is one input among
several that act on the same number, and it is far smaller than the effect of antihypertensive
treatment. Stopping prescribed medication because you have started walking is a decision that belongs
with the doctor who prescribed it, not with a study summary.
Why quote confidence intervals rather than p-values?
Because the interval tells you the size of the effect as well as whether it exists. A systolic
reduction of 3.58 mmHg with an interval of −5.19 to −1.97 says the data are consistent with a reduction
somewhere between about 2 and 5 mmHg. A p-value would tell you only that the result was unlikely by
chance, which is the less useful half of the information.
Sources
- Murtagh EM, Nichols L, Mohammed MA, Holder R, Nevill AM, Murphy MH. The effect of walking on risk
factors for cardiovascular disease: an updated systematic review and meta-analysis of randomised control
trials. Preventive Medicine, 2015. PMID 25579505. 32 articles; walking as the only treatment,
≥4 weeks, inactive at baseline, against a no-exercise comparator. Systolic −3.58 mmHg (−5.19 to −1.97);
diastolic −1.54 mmHg (−2.83 to −0.26); body weight −1.37 kg (−1.75 to −1.00); BMI −0.53 kg/m²
(−0.72 to −0.35); body fat −1.22% (−1.70 to −0.73); VO₂max +3.04 mL/kg/min (2.48 to 3.60); failed to
alter blood lipids —
PubMed record - US Department of Health and Human Services, Physical Activity Guidelines for Americans —
health.gov
Trial count, inclusion criteria and all effect sizes with
confidence intervals above are taken from the published abstract of the meta-analysis, checked August
2026.
